About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

WITHDRAWNPhase 1

Frespaciguat (MK-5475) in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

A Study to Assess the Safety, Tolerability, and Pharmacodynamics of Multiple Dose MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia

NCT04425733•Merck Sharp & Dohme LLC

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Coronavirus Disease 2019 (COVID-19)PneumoniaHypoxemia

Interventions

Frespaciguat

Placebo

Key Dates

Start Date

July 7, 2020

Primary Completion Date

November 10, 2020

Completion Date

November 10, 2020

Last Updated

May 15, 2025

Related Studies

RECRUITINGPhase 1

Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years

NCT07428759

Pneumonia, Bacterial

Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia

NCT06743529

Ventilator-Associated Pneumonia (VAP)

RECRUITINGPhase 4

Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

NCT07409727

Ventilation Acquired Pneumonia

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

NCT06966284

Bacteremia Caused by Gram-Negative BacteriaBacterial Pneumonia

RECRUITINGEARLY Phase 1

iNO300 Therapy in Critically Ill Patients With Pneumonia

NCT06950294

Critical IllnessPneumonia

RECRUITINGPhase 4

Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP

NCT06494072

Community Acquired Pneumonia in Children

View all related studies

Sponsors

Lead Sponsor

Merck Sharp & Dohme LLC

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 15, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions